Short Interest in Enhabit, Inc. (NYSE:EHAB) Drops By 5.4%

Enhabit, Inc. (NYSE:EHAB - Get Free Report) was the recipient of a large decline in short interest in December. As of December 31st, there was short interest totalling 1,220,000 shares, a decline of 5.4% from the December 15th total of 1,290,000 shares. Currently, 2.8% of the company's stock are short sold. Based on an average daily volume of 375,300 shares, the days-to-cover ratio is presently 3.3 days.

Insider Transactions at Enhabit

In related news, Director Stuart M. Mcguigan purchased 15,000 shares of Enhabit stock in a transaction on Tuesday, December 10th. The stock was acquired at an average price of $8.81 per share, for a total transaction of $132,150.00. Following the completion of the transaction, the director now directly owns 46,810 shares in the company, valued at $412,396.10. This represents a 47.15 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jeffrey Bolton acquired 4,000 shares of Enhabit stock in a transaction dated Thursday, December 12th. The stock was purchased at an average cost of $8.69 per share, with a total value of $34,760.00. Following the completion of the purchase, the director now owns 98,144 shares of the company's stock, valued at approximately $852,871.36. This represents a 4.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.90% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. AREX Capital Management LP increased its stake in shares of Enhabit by 2.5% in the second quarter. AREX Capital Management LP now owns 2,472,662 shares of the company's stock worth $22,056,000 after acquiring an additional 59,353 shares during the period. Systematic Financial Management LP boosted its holdings in Enhabit by 12.2% in the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company's stock valued at $14,522,000 after purchasing an additional 199,235 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Enhabit by 1.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,756,745 shares of the company's stock worth $15,669,000 after purchasing an additional 26,753 shares during the period. Geode Capital Management LLC raised its stake in shares of Enhabit by 0.9% during the 3rd quarter. Geode Capital Management LLC now owns 1,137,458 shares of the company's stock valued at $8,987,000 after buying an additional 10,538 shares during the last quarter. Finally, Jane Street Group LLC lifted its holdings in shares of Enhabit by 514.3% in the 3rd quarter. Jane Street Group LLC now owns 901,084 shares of the company's stock valued at $7,119,000 after buying an additional 754,395 shares during the period.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on EHAB shares. Jefferies Financial Group upgraded Enhabit from a "hold" rating to a "buy" rating and raised their price target for the stock from $8.25 to $9.50 in a research report on Monday, December 9th. Leerink Partners reiterated a "market perform" rating and set a $8.00 price target (down from $8.50) on shares of Enhabit in a report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $8.75.

Enhabit Stock Up 0.2 %

Shares of EHAB traded up $0.02 during mid-day trading on Friday, hitting $7.99. The company's stock had a trading volume of 217,365 shares, compared to its average volume of 250,018. The firm has a market capitalization of $401.49 million, a price-to-earnings ratio of -3.44 and a beta of 1.82. The company's 50-day moving average is $7.83 and its 200-day moving average is $8.11. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit has a 52-week low of $6.85 and a 52-week high of $11.74.

Enhabit (NYSE:EHAB - Get Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.01). The firm had revenue of $253.60 million for the quarter, compared to analysts' expectations of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same period in the previous year, the company earned $0.03 EPS. On average, equities research analysts forecast that Enhabit will post 0.22 EPS for the current fiscal year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.